WESTLAKE GENETECH TO PRESENT AT BIOTECH SHOWCASE™ 2024

Hangzhou/January 8th–Westlake Genetech, today announced that it is presenting at Biotech Showcase™ 2024.

Lijia Ma, Founder, and Chairman of the Board will be presenting Westlake Genetech at Biotech Showcase.

[ INFORMATION ]

TOPIC: Gene Therapy powered by AIDD

Date: Wednesday, January 10, 2024

Time: 10:45 AM

Location: Yosemite C (Ballroom Level) Hilton San Francisco - Union Square 333 O'Farrell Street

“We are delighted to participate in this year's Biotech Showcase and share our progress in AI-powered gene therapy in terms of safety, efficacy, and accessibility, as well as highlight our AAV Evolution Platform. We hope to showcase our unique strengths and development potential in the field of biotechnology, seek deeper interaction and connection with industry partners and investors, and explore future cooperation opportunities to further promote innovation and development of the industry,” said Lijia Ma.

Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year in San Francisco during the course of one of the industry's largest gatherings and busiest weeks.

“We are delighted that Westlake Genetech will be joining us in San Francisco and presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime opportunity for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”

[ ABOUT BIOTECH SHOWCASE ]

Biotech Biotech Showcase is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 16th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.

[ ABOUT WESTLAKE GENETECH ]

Westlake Genetech is an innovative biotech company. We focus on the rapid development of first-in-class drugs by integrating the 3H (high throughput, high precision, high dimension) biotechnological data production and deep learning modeling. By building technology-driven gene therapy technology platforms and developing differentiated self-developed gene therapy products, we are committed to mapping the full-process implementation of AI-powered gene therapy.

Our self-developed AI-powered full-chain gene therapy technology platform has evolved to generate a large number of non-liver-targeted AAV capsids, developed gene editing tools with independent intellectual property rights, explored new targets, and developed safe, efficient, and accessible gene therapy innovative therapies for rare diseases, tumors, and other diseases. With the platform's empowerment, it will effectively expand the scope of gene therapy indications, significantly shorten the pipeline development time, improve the pipeline R&D efficiency, and achieve the optimization of cost reduction and efficiency improvement and technology tool selection. We are rapidly advancing our technological achievements to the field of disease treatment, laying out ex vivo and in vivo gene therapy, developing differentiated gene therapy products, and solving more unmet clinical needs.

Contacts：bd@westlakegenetech.com